Central Pacific Bank - Trust Division’s Alnylam Pharmaceuticals ALNY Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155K	Sell	515 -1,898	-79%	-$572K	0.02%	532
2026 Q1	$798K	Hold	2,413	–	–	0.1%	205
2025 Q4	$960K	Sell	2,413 -222	-8%	-$98.2K	0.12%	182
2025 Q3	$1.2M	Sell	2,635 -383	-13%	-$156K	0.15%	150
2025 Q2	$984K	Buy	3,018 +365	+14%	+$101K	0.13%	169
2025 Q1	$716K	Buy	2,653 +1,648	+164%	+$424K	0.1%	204
2024 Q4	$236K	Sell	1,005 -20	-2%	-$5.26K	0.03%	417
2024 Q3	$282K	Sell	1,025 -25	-2%	-$6.51K	0.04%	398
2024 Q2	$255K	Hold	1,050	–	–	0.03%	487
2024 Q1	$161K	Buy	+1,050	New	+$175K	0.02%	594

Other funds holding ALNY

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Spectrum Planning & Advisory Services San Diego, California $223M AUM 17.29% 1-Year Est. Return

Laurie J. Hall Trustee $322M AUM 33.73% 1-Year Est. Return